Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

Formula One team owner Eddie Jordan has died, aged 76, after a year-long battle with prostate and bladder cancer. The Irishman revealed in December he was suffering from bladder and prostate ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...

Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease. Prostate cancer is the most common cancer among men and the ...

ABOUT 55,000 new prostate cancer cases are recorded every year in the UK. Bladder cancer is less common, with around 10,500 new cases. For both types, cancer can start in one area of the body and ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

At-home tests for men worried about prostate cancer can give inconsistent and inaccurate results, BBC News has found. The tests, which resemble a Covid lateral flow strip, turn positive if a high ...

The FDA approved a radioligand therapy for earlier use prior to chemotherapy in patients with prostate-specific membrane ...